Header Logo

Connection

MUZAFFAR H QAZILBASH to Alkylating Agents

Back to Details
This is a "connection" page, showing publications MUZAFFAR H QAZILBASH has written about Alkylating Agents.
MUZAFFAR H QAZILBASH
Connection Strength
0.057
Alkylating Agents
  1. Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. Am J Hematol. 2024 05; 99(5):836-843.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.